Rick Hockett has been named chief medical officer at Affymetrix, the firm said this week.
Hockett joined Affy in March from Eli Lilly, where he was medical fellow and director of genomic medicine. Prior to Lilly, he spent seven years on staff at the University of Alabama Birmingham Hospital, where he was professor of pathology and head of clinical immunology and molecular diagnostics.
SRU Biosystems last week named Jane Clark and Rick Loomis as senior sales executives for its North American sales division, and appointed Steve Shamah as its director of cell biology.
Clark most recently served as a senior sales executive at VisEn Medical, and previously held sales positions at Amaxa, Affymetrix, and Life Technologies. Loomis was director of industrial sales at Lonza, and has also worked at Genetix, Acea, and PerkinElmer. Prior to joining SRU, Shamah was a senior principal investigator at Archemix. He also held positions at Hydra Biosciences and Phylos.